Artesunate injection is a first-line treatment for severe malaria, derived from artemisinin and administered intravenously or intramuscularly to patients who cannot take oral medication. It is recommended by the World Health Organization for severe falciparum malaria, a condition that remains a major cause of mortality in endemic regions. The market is expanding steadily, driven by the persistent burden of severe malaria, expanding access programs in endemic countries, and the drug's established clinical superiority over older treatments.

According to recent market analysis, the global Artesunate Injection Market is projected to grow at a steady CAGR through 2035, reflecting both the continuing disease burden and the public health investment in effective injectable antimalarials.

Persistent Burden of Severe Malaria

The primary driver is the disease burden. Malaria remains a leading cause of illness and death in sub-Saharan Africa and parts of Asia and Latin America, and severe cases require immediate injectable therapy. Artesunate's clinical superiority over quinine in reducing mortality has made it the standard of care, sustaining demand across endemic regions.

Access Expansion and Public Health Programs

A second driver is access. International procurement agencies, national malaria programs, and donor-funded initiatives have expanded the availability of artesunate injection in low-income settings. As treatment guidelines standardize on artesunate, procurement volumes are supported by policy rather than discretionary spending.

People Also Ask

What is the market size of artesunate injection?
The artesunate injection market is projected to grow at a steady CAGR through 2035, driven by the persistent burden of severe malaria.

What is artesunate injection used for?
It is used to treat severe falciparum malaria in patients who cannot take oral medication, delivering rapid antimalarial action.

Regional dynamics shape the market. Africa accounts for the largest share of demand given its malaria burden, while Asia-Pacific and South America contribute meaningfully, and high-income markets maintain smaller stockpiles for imported cases.

Tags: #ArtesunateInjection #MalariaTreatment #SevereMalaria #Antimalarials #GlobalHealth